GlassScriptPhysician profile
Ahmed Soliman
NPI 1356590970
$1,015.91
in general payments reported to CMS, 2019-2025
17 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $91.18 · 2022: $137 · 2023: $154 · 2024: $19.85 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $150.94 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $129.18 | 2020-2025 | Cardiomems |
| Boston Scientific Corporation | $113.30 | 2019 | |
| Heartflow, INC. | $104.27 | 2023 | Ffrct |
| Medtronic Vascular, INC. | $91.41 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $81.19 | 2022 | |
| Siemens Medical Solutions USA, INC. | $64.20 | 2019-2025 | Syngo Dynamics |
| Novo Nordisk INC | $61.03 | 2019-2025 | Wegovy |
| Amgen INC. | $49.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $36.04 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $26.40 | 2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $23.59 | 2023 | |
| Astellas Pharma US INC | $22.85 | 2019 | |
| Shockwave Medical, INC | $19.85 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $15.15 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.56 | 2019 | |
| Tactile Systems Technology INC | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.